AI Article Synopsis
- Revascularisation of renal arterial stenosis in acute situations like severe hypertension or acute renal failure has inconsistent results in studies, leading to no recommendation for the procedure in cases of renal failure.
- Current guidelines suggest that revascularisation and optimal medical management yield similar long-term renal function outcomes.
- A case study highlighted a 66-year-old diabetic male with severe renal function decline after the use of irbesartan, whose renal function improved significantly just 5 days after undergoing angioplasty and stenting of the right renal artery.
Article Abstract
Revascularisation of renal arterial stenosis in acute settings, such as uncontrolled arterial hypertension, flash pulmonary oedema and/or acute renal failure, has shown controversial results in observational and prospective studies. Current guidelines do not recommend revascularisation in the occurrence of renal failure as revascularisation and best medical treatment have shown similar long-term outcomes on renal function. We describe a case of acute degradation of the renal function (with oligo-anuria and a peak creatinine of 462 µmol/L) after the re-introduction of an angiotensin-II receptor blocker (irbesartan) in a 66-year-old Caucasian diabetic male patient with bilateral renal stenosis and a right-sided single-functioning kidney, with a rapid improvement of the renal function which normalized 5 days after percutaneous angioplasty and stenting of the right renal artery.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629318 | PMC |
| http://dx.doi.org/10.1177/2050313X231209639 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!